Finance

Beta
Lists
ANIK:NASDAQ
Anika Therapeutics Inc
$14.53
-2.48%
(-0.37) 1D
$14.53
0.00% (0.00)
After hours
Closed: May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANIK...
Open
$14.85
High
$15.79
Low
$14.50
Mkt. cap
193.33M
Avg. vol.
104.61K
Volume
99.74K
52-wk high
$16.24
52-wk low
$7.90
EPS
-$0.79
Beta
0.16
Shares outstanding
13.31M
No. of employees
235
Open
$14.85
High
$15.79
Low
$14.50
Mkt. cap
193.33M
Avg. vol.
104.61K
Volume
99.74K
52-wk high
$16.24
52-wk low
$7.90
EPS
-$0.79
Beta
0.16
Shares outstanding
13.31M
No. of employees
235
News stories
From sources across the web
About Anika Therapeutics Inc
CEO-
Employees235
Founded1983
HeadquartersBedford, Massachusetts, United States
SectorBiotechnology
Websiteanika.com
Last report
Apr 29, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.27 /
0.00%miss
Revenue / Est. (USD)
29.61M / 28.14M
+5.22%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
28.22M
27.82M
30.62M
29.61M
Cost of goods sold
13.86M
12.23M
11.44M
10.62M
Cost of revenue
13.86M
12.23M
11.44M
10.62M
Research and development expenses
6.31M
6.95M
6.45M
6.71M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.23M
11.87M
12.08M
17.77M
Operating expense
18.54M
18.82M
18.53M
24.48M
Total operating expenses
32.40M
31.05M
29.97M
35.10M
Operating income
-4.18M
-3.23M
646.00K
-5.49M
Other non operating income
-
-
-
-
EBT including unusual items
-3.97M
-2.24M
764.00K
-4.82M
EBT excluding unusual items
-3.97M
-2.24M
764.00K
-4.82M
Income tax expense
681.00K
939.00K
-1.04M
235.00K
Effective tax rate
-17.17%
-41.99%
-135.73%
-4.87%
Other operating expenses
-
-
-
-
Net income
-3.97M
-2.33M
292.00K
-5.06M
Net profit margin
-14.07%
-8.37%
0.95%
-17.07%
Earnings per share
-0.13
0.04
0.31
0.27
Interest and investment income
214.00K
997.00K
118.00K
667.00K
Interest expense
-
-
-
-
Net interest expenses
214.00K
997.00K
118.00K
667.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.91M
-1.83M
1.96M
-4.08M
Gain or loss from assets sale
-505.00K
-451.00K
790.00K
-52.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer